Ex Parte Pinchuk et al - Page 8

                Appeal 2007-1585                                                                             
                Application 10/383,268                                                                       
                However, regarding mating ends of the prosthetic modules, Fogarty                            
                indicates that “[i]deally, the interface ends are interchangeable, but they may              
                alternatively comprise distinct inner and outer mating pairs.   In a                         
                particularly preferred embodiment, multiple prosthetic body modules 94                       
                may be directly coupled together to form a single composite prosthesis.”                     
                (Fogarty, col. 10, ll. 48-51).   Fogarty also states that, “the length, cross-               
                section, axial bend angle, axial flexibility, resilient spring force … and the               
                like” can be varied to offer a variety of prosthetic characteristics.   (Fogarty,            
                col. 10, ll. 52-56).  Fogarty further states that “[m]odular sections of the                 
                prostheses, or ‘prosthetic modules,’ may be selectively combined to form a                   
                composite prosthesis having characteristics which are tailored to the specific               
                requirements of the patient.”   (Fogarty, col. 3, ll. 9-16).   Thus, as indicated            
                above, one of ordinary skill in the art reading Fig. 4 in conjunction with the               
                disclosure, would have understood that Fogarty was not limited to the                        
                dashed line connections of Figure 4, but contemplated an entire prosthesis                   
                composed of modules 94, or comprising various module shapes selected                         
                based on the characteristics of the blood vessel to be treated.   The rejection              
                of claim 35 is affirmed.  Claims 30-33 fall with claim 35.                                   

                                              CONCLUSION                                                     
                In summary, we:                                                                              
                      Affirm the rejection of claims 25-28 and 30-35 over Fogarty.                           







                                                     8                                                       

Page:  Previous  1  2  3  4  5  6  7  8  9  Next

Last modified: September 9, 2013